SOX9 expression decreases survival of patients with intrahepatic cholangiocarcin
- This topic has 0 replies, 1 voice, and was last updated 5 years, 5 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
SOX9 expression decreases survival of patients with intrahepatic cholangiocarcinoma by conferring chemoresistance.
https://www.ncbi.nlm.nih.gov/pubmed/30420613
Viewing 1 post (of 1 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.